BRIEF published on 10/13/2026 at 10:05, 4 hours 11 minutes ago PL BioScience présente PL Synergy pour une recherche améliorée sur les CSM PL BioScience Synergie PL Recherche MSC Extension Sans Xéno Kit De Culture Cellulaire
BRIEF published on 10/13/2026 at 10:05, 4 hours 11 minutes ago PL BioScience Introduces PL Synergy for Enhanced MSC Research PL BioScience PL Synergy MSC Research Xeno-free Expansion Cell Culture Kit
PRESS RELEASE published on 10/13/2026 at 10:00, 4 hours 16 minutes ago PL BioScience Launches PL Synergy to Simplify and Standardize MSC Research PL BioScience launches PL Synergy, a two-component culture kit designed to simplify and standardize MSC research. The kit combines PL Base and PL Boost for streamlined xeno-free MSC expansion PL BioScience PL Synergy MSC Research Culture Kit Xeno-free
BRIEF published on 06/16/2026 at 10:05, 3 months 27 days ago PL BioScience accueille Maik W. Jornitz au sein de son conseil d'administration. Conseil D'administration Croissance Biopharmaceutique Lysat Plaquettaire Humain PL BioScience Maik W. Jornitz
BRIEF published on 06/16/2026 at 10:05, 3 months 27 days ago PL BioScience Welcomes Maik W. Jornitz to Board of Directors Board Of Directors Biopharmaceutical Growth Human Platelet Lysate PL BioScience Maik W. Jornitz
PRESS RELEASE published on 06/16/2026 at 10:00, 3 months 27 days ago PL BioScience Appoints Maik W. Jornitz to Board of Directors PL BioScience GmbH appoints Maik W. Jornitz to its board of directors, bringing four decades of biopharmaceutical experience to accelerate global growth Board Of Directors Biopharmaceutical Global Growth PL BioScience GmbH Maik W. Jornitz
BRIEF published on 02/20/2026 at 09:05, 7 months 21 days ago PL BioScience conclut un accord de distribution exclusif au Japon avec Summit Pharmaceuticals Accord De Distribution Marché Japonais PL BioScience Suppléments Pour Culture Cellulaire Summit Pharmaceuticals
BRIEF published on 02/20/2026 at 09:05, 7 months 21 days ago PL BioScience Secures Exclusive Japanese Distribution Deal with Summit Pharmaceuticals Distribution Agreement Japanese Market PL BioScience Cell Culture Supplements Summit Pharmaceuticals
PRESS RELEASE published on 02/20/2026 at 09:00, 7 months 21 days ago PL BioScience Signs Exclusive Japanese Distribution Agreement with Summit Pharmaceuticals International PL BioScience signs exclusive distribution agreement with Summit Pharmaceuticals International for cell culture supplements in Japan, marking their first partnership in the country Japanese Market Exclusive Agreement PL BioScience Cell Culture Supplements Summit Pharmaceuticals International
BRIEF published on 02/11/2026 at 10:05, 8 months 2 days ago PL BioScience Secures Certification from Japan's PMDA Regenerative Medicine Human Platelet Lysate PL BioScience PMDA Certification ELAREM™ Ultimate-FD PLUS
Published on 10/13/2026 at 14:00, 16 minutes ago Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold
Published on 10/13/2026 at 14:00, 16 minutes ago Fermi Signs Credit Support Agreement with AMD and Announces Partnership
Published on 10/13/2026 at 13:30, 46 minutes ago British Columbia Court Declares The Helix Resources Joint Venture on The Gold Basin Property is Set Aside and is Unenforceable
Published on 10/13/2026 at 13:30, 46 minutes ago Digi Power X Announces $200 Million Debt Financing Commitment to Support Completion of Alabama AI Data Center and Provides Expansion Update
Published on 10/13/2026 at 13:01, 1 hour 15 minutes ago CoTec Holdings Corp. Notes HyproMag USA Secures Power and Advances Project Readiness for Texas Rare Earth Magnet Recycling and Manufacturing Hub
Published on 10/13/2026 at 14:05, 11 minutes ago IDC Raises 2029 Forecast for OCP-Recognized Infrastructure Spending by 2.7x to $800 Billion
Published on 10/13/2026 at 14:00, 16 minutes ago Le plan « Transports 45 » fait fi des besoins de la Suisse en matière de mobilité
Published on 10/13/2026 at 14:00, 16 minutes ago Eckert & Ziegler and TerThera Sign Supply Agreement to Bring Next-Generation GMP Terbium-161 Radiopharmaceutical Therapies to Brazilian Patient
Published on 10/13/2026 at 12:31, 1 hour 45 minutes ago Il Perù è riconosciuto come "Migliore destinazione del Sud America" ai World Travel Awards
Published on 10/13/2026 at 12:29, 1 hour 47 minutes ago Le Pérou est reconnu comme la « Meilleure destination d'Amérique du Sud » aux World Travel Awards
Published on 10/13/2026 at 09:04, 5 hours 12 minutes ago Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards
Published on 10/12/2026 at 17:59, 20 hours 17 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:59, 20 hours 17 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 7 au 9 octobre 2026
